ASHPOfficial

This mini-series will focus on how to get started in using data to drive decision-making and highlight institutions with successful implementations. This podcast is intended to provide tips on how to begin gaining support for data and analytics resources within a pharmacy department. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide listeners with perspectives and case study on effective methods to improve a pharmacy department's team engagement and management of the front-lines. In this podcast, we will share practical examples used at both a large academic facility and a smaller community hospital to improve daily communication, manager feedback techniques, and encourage staff engagement.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Rapid sequence intubation and management of the recently intubated patient is a common scenario faced in any emergency department. This podcast will discuss the role of the EM pharmacist, potential strategies for success, and potential pitfalls and controversies regarding the management of these patients. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a Wellness Wednesday conversation for our second installation of the financial wellness series featuring members of the Section of Clinical Specialist and Scientists (SCSS) and the New Practitioner's Forum (NPF). This podcast will share insights into things to begin thinking about for retirement including savings, differences between retirement plans, and how different types of employment can lead to different strategies.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

We chat with Dr. Paul Szumita and Dr. Jeffrey Pearson, both of Brigham and Women’s Hospital in Boston, MA about updates on the use of antiviral therapies, anti-inflammatory management, as well as supportive care in patients with COVID-19.  For more on this topic, please see  https://elearning.ashp.org/COVID-19 and Expert Insight articles at https://ashpadvantage.com/expert-insight/.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast discusses the value of integrating a pharmacist into a multidisciplinary team. Over the evolution of the profession of pharmacy, different departments and disciplines have identified the need and benefit of the addition of a pharmacist. As opportunities continue to flourish and expand, pharmacists have discovered traditional and non-traditional leadership roles amongst other health care professions all throughout different health-systems. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In today's episode, we discuss the importance and benefits of embracing DEI, while also exploring how continuous learning and intentionality can be the impetus for impactful change.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Recent updates to asthma guidelines suggest that treatments may be used ‘as needed’ in certain patient populations. Additionally, newer monoclonal antibodies are providing an alternative to systemic glucocorticoids for severe asthma control and exacerbation prevention. The rapid release of multiple agents and changes to national/international guidelines requires a review of asthma management. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Recent updates to asthma guidelines suggest that treatments may be used ‘as needed’ in certain patient populations. Additionally, newer monoclonal antibodies are providing an alternative to systemic glucocorticoids for severe asthma control and exacerbation prevention. The rapid release of multiple agents and changes to national/international guidelines requires a review of asthma management. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast is the first of three Wellness Wednesday conversations focusing on financial wellness. During this episode, members from ASHP New Practitioners Forum and the Section of Clinical Specialists and Scientists (SCSS) discuss personal finances, specifically key strategies and insights related to student loans. If you are student pharmacist or pharmacist wanting to learn more about navigating your loans including options for repayment, consolidation, or refinancing this podcast is a must listen.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.